Yervoy 200 contains Ipilimumab, 200mg/40ml, supplied as injection (iv). Manufacturer: Bristol Myers Squibb. Therapeutic class: Immunotherapy CTLA-4.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.